Latest Capital Markets News

HealthCo Healthcare and Wellness REIT reported a sharp increase in half-year losses to $15.4 million, alongside a portfolio reduction and steady funds from operations, highlighting a complex transition phase.

Tivan Limited has secured $9 million through a share placement backed by institutional and sophisticated investors, aiming to fund key fluorite and vanadium projects alongside general working capital needs.

Lindian Resources has appointed seasoned financial advisor Henk Ludik to advance funding negotiations for its Kangankunde Rare Earths Project amid rising investor interest and a non-binding $50 million package with Gerald Group.

Alliance Aviation Services has reported a robust half-year performance with a 9.5% increase in statutory profit before tax and record flight hours, underpinned by fleet expansion and strong wet lease demand.

Vanadium Resources Limited (ASX: VR8) has been reinstated to trading following a suspension linked to new funding arrangements, signaling renewed operational momentum.

Solis Minerals appoints Mitch Thomas as CEO, shifting Mike Parker to Technical Director, ahead of a major 2025 drilling campaign in Peru's copper-rich belt.

Trigg Minerals has secured a dual listing on the U.S. OTCQB market, enhancing accessibility for American investors and positioning itself for critical funding opportunities.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Elixir Energy Limited has had its ASX trading suspension lifted following a pivotal announcement about expanding its Taroom Trough assets and initiating a capital raise.

Resouro Strategic Metals Inc. posted a $5.28 million net loss for the nine months ended December 31, 2024, reflecting increased exploration and administrative expenses as it advances its Tiros Titanium and Rare Earth Elements Project. The company bolstered its balance sheet with a successful ASX dual listing and private placements but faces ongoing challenges to sustain operations.

Macquarie Group’s 3Q25 trading update reveals strong growth in its annuity-style businesses, while markets-facing segments face pressure from subdued commodity markets, resulting in a mixed financial performance for the year to date.

Macquarie Group's 3Q25 trading update reveals strong growth in annuity-style businesses offset by a significant decline in markets-facing segments due to subdued commodity markets. The group's capital position remains robust, comfortably exceeding regulatory requirements.